Mikhail, Davis embody the FDA’s stabilization, Seehafer signals AI revolution is coming

Summary

The FDA has solidified leadership under Karim Mikhail (CBER) and Michael Davis (CDER) to stabilize operations following former Commissioner Marty Makary's tenure. Jared Seehafer has been appointed as the first-ever Deputy Commissioner focused on artificial intelligence.